NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that Medidata Cloud, the Intelligent Platform for Life Sciences, is streamlining the management of medical images for the World ...
Between 2007 and 2009 inclusive, 50 female patients with human epidermal growth factor receptor 2–positive breast cancer received adjuvant trastuzumab after doxorubicin. Serial MUGA, 2D TTE, RT3D TTE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback